Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groups.
Autor: | McLeod, HL, Murray, LS, Wanders, J, Setanoians, A, Graham, MA, Pavlidis, N, Heinrich, B, ten Bokkel Huinink, WW, Wagener, DJTh, Aamdal, S, Verweij, J, McLeod, H L, Murray, L S, Graham, M A, ten Bokkel Huinink, W W, Wagener, D J |
---|---|
Zdroj: | British Journal of Cancer; Dec1996, Vol. 74 Issue 12, p1944-1948, 5p |
Databáze: | Complementary Index |
Externí odkaz: |